前列腺癌手术去势与GnRHa治疗后的心血管缺血事件风险:全国队列研究
该研究利用台湾全民健康保险研究数据库分析14,715例前列腺癌患者,比较双侧睾丸切除术与促性腺激素释放激素激动剂(GnRHa)治疗后的心血管缺血事件风险。中位随访3.3年,两组总体心血管缺血事件风险相似(HR 1.16;95%CI 0.97-1.38),但随访前1.5年内手术去势组事件更多(HR 1.40;95%CI 1.04-1.88),尤其在≥65岁、高血压、Charlson合并症指数≥3及既往有心肌梗死、缺血性卒中或冠心病史的患者中。
要点
- 两组总体心血管缺血事件风险相似,HR 1.16(95%CI 0.97-1.38)。
- 前1.5年手术去势组心血管缺血事件高于GnRHa组,HR 1.40(95%CI 1.04-1.88)。
- 高龄、高血压、合并症多及心血管病史者手术去势后早期风险更高。
核心结论
- 与双侧睾丸切除术相比,使用GnRHa不增加前列腺癌患者心血管缺血事件风险。
- 手术去势与老年及有心血管合并症患者在开始雄激素剥夺治疗后1.5年内较高的心血管缺血事件率相关。
研究设计与样本
- 患者接受双侧睾丸切除术或GnRHa治疗,采用倾向评分逆概率治疗加权调整基线协变量不平衡,Cox回归模型识别心肌梗死、缺血性卒中及心脏相关并发症的风险因素。
主要发现
- 3,578例(24.3%)接受双侧睾丸切除术,11,137例(75.7%)接受GnRHa治疗。
- 中位随访3.3年,两组心血管缺血事件(心肌梗死或缺血性卒中)风险相似,HR 1.16(95%CI 0.97-1.38)。
- 随访前1.5年内,手术去势组心血管缺血事件高于GnRHa组,HR 1.40(95%CI 1.04-1.88),尤其在≥65岁、高血压、Charlson合并症指数≥3及既往有心肌梗死、缺血性卒中或冠心病史的患者中。
临床怎么用
- 研究结果可帮助临床医生为个体患者选择最佳去势策略。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Purpose Our aim was to determine whether cardiovascular (CV) risk in patients with prostate cancer (PCa) differs between those who receive androgen-deprivation therapy by surgical castration and those who receive gonadotropin-releasing hormone agonist (GnRHa) therapy. Patients and Methods By using the Taiwan National Health Insurance Research Database, we analyzed data from 14,715 patients with PCa diagnosed from January 1, 1997, through December 31, 2011. The patients were treated with bilateral orchiectomy or GnRHa therapy. We used inverse probability of treatment weighting with propensity scores to adjust for the imbalance in covariate baseline values between these two groups. Cox regression models were used to identify risk factors for myocardial infarction (MI), ischemic stroke (IS), and cardiac-related complications. Results Overall, 3,578 patients with PCa (24.3%) underwent bilateral orchiectomy and 11,137 patients (75.7%) received GnRHa therapy. Both groups had a similar risk of CV ischemic events (ie, MI or IS; hazard ratio, 1.16; 95% CI, 0.97 to 1.38) during a median follow-up time of 3.3 years. However, during the first 1.5 years of follow-up, there were higher CV ischemic events in the orchiectomy group than in the GnRHa group (hazard ratio, 1.40; 95% CI, 1.04 to 1.88), particularly in patients who were ≥ 65 years of age, had hypertension, had a Charlson comorbidity index score ≥ 3, and had a previous history of MI, IS, or coronary heart disease. Conclusion Compared with bilateral orchiectomy, use of GnRHa does not increase the risk of CV ischemic events in patients with PCa. Nonetheless, orchiectomy is associated with higher rates of CV ischemic events in older patients and those with a history of CV comorbidities within 1.5 years of initiating androgen-deprivation therapy. These findings can help clinicians decide on the optimal castration strategy for individual patients.
引用
- Chen DY, See LC, Liu JR, et al. Risk of Cardiovascular Ischemic Events After Surgical Castration and Gonadotropin-Releasing Hormone Agonist Therapy for Prostate Cancer: A Nationwide Cohort Study. J Clin Oncol. 2017. PMID: 28968166. doi:10.1200/JCO.2016.71.4204
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。